Vincent Perrone | Director of Corporate Communication |
Steve Shallcross | Acting CEO and CFO |
Dr. Michael Kaleko | SVP, R&D |
Dr. Vince Wacher | Product Development and Partnering |
Katherine Xu | William Blair |
Jim Molloy | AGP |
Good afternoon and welcome to the Synthetic Biologics 2018 Third Quarter Investor Conference Call. All participants will be in a listen-only mode. [Operator Instructions] After today's presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note this event is being recorded. At this time, I would like to turn the conference over to Vincent Perrone, Director of Corporate Communications at Synthetic Biologics.